Dialysis center investing: the DSO model and operator economics
Dialysis center ownership is dominated by two operators, but physician-owned dialysis is making a comeback. Here’s the economics.
Author: Pouyan Golshani
Founder of GigHz. Physician, builder, and deep-tech advisor exploring the intersections of advanced materials, medicine, and market strategy. I help innovators refine ideas, connect to the right stakeholders, and bring meaningful solutions to life — one signal at a time.
Dialysis access OBL co-ownership: how nephrologists and IR build referral-economics joint ventures
Nephrologists who refer dialysis access patients to IR are sitting on a referral-equity arbitrage most never act on. Here’s how the joint venture works.
AI tools for infectious disease: stewardship, micro lab, and CDS
ID AI tools have moved beyond press releases. Here’s the directory of tools with active hospital deployments.
Antimicrobial stewardship consulting: side income for ID physicians
ID physicians have unique consulting opportunities — antimicrobial stewardship, hospital epi, FDA work. Here’s how to structure 1099 income.
Real estate for ID physicians: the long-game compounding strategy
Lower income means slower portfolio building, but the principles still work. Here’s the multi-decade plan for ID physicians.
PSLF for ID physicians: the 501(c)(3) and academic opportunity
Academic ID is one of the cleanest PSLF eligibility cases. Here’s how to make sure you don’t sabotage the 10-year clock.
Tax planning for infectious disease physicians: optimization on a lower income
ID is one of the lowest-paid medical specialties. The tax planning matters more, not less. Here’s the playbook for income-modest, mission-driven…
Referral pulse and growth for heme/onc practices
Hematology practices often miss inbound referrals from PCPs and surgical specialties. Here’s how to measure and capture them.
AI tools for hematology: anticoagulation, peripheral smear, and CDS
Heme AI is moving fast in peripheral smear interpretation, anticoag dosing, and CDS. Here’s the tool directory.
Real estate for hematologists: the depreciation play for high-K-1 income
K-1 income from infusion practices shields differently than W-2. Here’s how real estate depreciation interacts with practice income.